RVACX | VEVYX | RVACX / VEVYX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 18 years | 12 years | - |
Gain YTD | 3.337 | 3.246 | 103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 284M | 19.2B | 1% |
Annual Yield % from dividends | 0.00 | 1.26 | - |
Returns for 1 year | 5.01 | 4.41 | 114% |
Returns for 3 years | -4.33 | 3.35 | -129% |
Returns for 5 years | -4.77 | 26.20 | -18% |
Returns for 10 years | -33.85 | 39.52 | -86% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FEAAX | 48.28 | -0.05 | -0.10% |
Fidelity Advisor Emerging Asia A | |||
MSVMX | 5.99 | -0.02 | -0.33% |
Morgan Stanley Vitality Portfolio C | |||
CLIFX | 20.30 | -0.08 | -0.39% |
Clifford Capital Partners Institutional | |||
JGSRX | 12.35 | -0.06 | -0.48% |
JHancock Global Shareholder Yield R2 | |||
VVONX | 22.39 | -0.47 | -2.06% |
Invesco Value Opportunities R5 |